Drugs / 13NH3
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03549598 | Jul 2018 → Oct 2019 | cardiac sarcoidosis | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 13NH3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03549598 ↗ |
| Modality | Diagnostic / imaging agent | “13NH3 PET/CT scan” NCT03549598 ↗ |
| Route | Intravenous | “Dose of 13NH3 will be administered intravenously” NCT03549598 ↗ |